-->
Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables

Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.

from NDTV Profit-Latest https://ift.tt/726GaeF

Related Posts

0 Response to "Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables"

Post a Comment

विज्ञापनको लागी सम्पर्क:

advertising articles 2

Advertise under the article